NO20053810L - Thiofenkarboksamider som inhibitorer av enzymet IKK-2 - Google Patents

Thiofenkarboksamider som inhibitorer av enzymet IKK-2

Info

Publication number: NO20053810L
Authority: NO; Norway
Prior art keywords: thiophenecarboxamides; inhibitors; ikk; enzyme; enzyme ikk
Prior art date: 2003-01-15

Application number

NO20053810A

Other languages

English (en)

Norwegian (no)

Other versions

NO20053810D0 (no

Inventor

Jeffrey Philip Poyser

David Andrew Morley

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-15

Filing date

2005-08-12

Publication date

2005-10-12

2005-08-12 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-08-12 Publication of NO20053810D0 publication Critical patent/NO20053810D0/no

2005-10-12 Publication of NO20053810L publication Critical patent/NO20053810L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Virology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Toxicology (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Child & Adolescent Psychology (AREA)

NO20053810A 2003-01-15 2005-08-12 Thiofenkarboksamider som inhibitorer av enzymet IKK-2 NO20053810L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0300091A SE0300091D0 (sv)	2003-01-15	2003-01-15	Novel compounds
PCT/GB2004/000106 WO2004063185A1 (fr)	2003-01-15	2004-01-13	Thiophene carboxamides utilises en tant qu'inhibiteurs de l'enzyme ikk-2

Publications (2)

Publication Number	Publication Date
NO20053810D0 NO20053810D0 (no)	2005-08-12
NO20053810L true NO20053810L (no)	2005-10-12

Family

ID=20290126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053810A NO20053810L (no)	2003-01-15	2005-08-12	Thiofenkarboksamider som inhibitorer av enzymet IKK-2

Country Status (20)

Country	Link
US (2)	US7553868B2 (fr)
EP (1)	EP1583756B9 (fr)
JP (1)	JP4568714B2 (fr)
KR (1)	KR20050098248A (fr)
CN (1)	CN1315820C (fr)
AT (1)	ATE374762T1 (fr)
BR (1)	BRPI0406774A (fr)
CA (1)	CA2512336A1 (fr)
CY (1)	CY1107817T1 (fr)
DE (1)	DE602004009283T2 (fr)
DK (1)	DK1583756T3 (fr)
ES (1)	ES2293206T3 (fr)
IL (1)	IL169478A (fr)
MX (1)	MXPA05007340A (fr)
NO (1)	NO20053810L (fr)
NZ (1)	NZ541219A (fr)
PT (1)	PT1583756E (fr)
SE (1)	SE0300091D0 (fr)
WO (1)	WO2004063185A1 (fr)
ZA (1)	ZA200505190B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003154D0 (en) *	2000-02-12	2000-04-05	Astrazeneca Uk Ltd	Novel compounds
SE0102616D0 (sv) *	2001-07-25	2001-07-25	Astrazeneca Ab	Novel compounds
SE0300092D0 (sv) *	2003-01-15	2003-01-15	Astrazeneca Ab	Novel compounds
SE0300091D0 (sv)	2003-01-15	2003-01-15	Astrazeneca Ab	Novel compounds
AU2004265140A1 (en)	2003-08-15	2005-02-24	Astrazeneca Ab	Substituted thiophenes and uses thereof
DE602004031777D1 (en) *	2004-01-05	2011-04-21	Astrazeneca Ab	Thiophenderivate als chk-1-inhibitoren
WO2005105777A1 (fr) *	2004-05-05	2005-11-10	Pharmacia & Upjohn Company Llc	Composes d'amide a substitution de thiophene pour le traitement de l'inflammation.
CN101583598B (zh) *	2007-01-15	2012-09-12	参天制药株式会社	具有IκB激酶β抑制活性的新型吲哚衍生物
JPWO2009096198A1 (ja) *	2008-02-01	2011-05-26	一般社団法人ファルマＩｐ	新規ビアリール誘導体
US20110039920A1 (en) *	2008-04-23	2011-02-17	Chroma Therapeutics Ltd.	Inhibitors of ikk-beta serine-theronine protein kinase
CN102089281A (zh) *	2008-07-14	2011-06-08	参天制药株式会社	具有氨基甲酰基、脲基及取代氧基的新型吲哚衍生物
GB0907120D0 (en) *	2009-04-24	2009-06-03	Chroma Therapeutics Ltd	Inhibitors of IKK-ß serine-threonine protein kinase
GB0913345D0 (en)	2009-07-31	2009-09-16	Astrazeneca Ab	New combination 802
WO2011061527A1 (fr)	2009-11-17	2011-05-26	Astrazeneca Ab	Combinaisons qui comprennent un modulateur du récepteur glucocorticoïde, destinées au traitement de maladies respiratoires
GB201016912D0 (en)	2010-10-07	2010-11-24	Astrazeneca Ab	Novel combination
GB201021979D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	New compound
GB201021992D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	Compound

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1468012A (en)	1973-08-09	1977-03-23	Beecham Group Ltd	2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de)	1985-05-17	1986-11-20	Bayer Ag, 5090 Leverkusen	Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
GB2195634B (en)	1986-10-01	1990-08-15	Roussel Lab Ltd	Thiophene derivatives
US5258357A (en) *	1989-10-07	1993-11-02	Basf Aktiengesellschaft	Carboxamides, their preparation and their use as herbicides
US5378703A (en) *	1990-04-09	1995-01-03	Alcon Laboratories, Inc.	Sulfonamides useful as carbonic anhydrase inhibitors
US5571810A (en) *	1990-06-11	1996-11-05	Fujisawa Pharmaceutical Co., Ltd.	Thiophene derivatives
US5514801A (en) *	1992-12-29	1996-05-07	Monsanto Company	Cyclic sulfone containing retroviral protease inhibitors
CA2260213C (fr)	1996-07-11	2005-03-29	Pfizer Inc.	Composes de pyridylpyrrole utiles comme antagonistes de l'interleukine et du facteur tnf
PT853083E (pt)	1997-01-06	2001-12-28	Pfizer	Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) *	1997-03-24	2004-10-26	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6117911A (en) *	1997-04-11	2000-09-12	Neorx Corporation	Compounds and therapies for the prevention of vascular and non-vascular pathologies
US6037340A (en)	1997-05-28	2000-03-14	Cadus Pharmaceutical Corporation	Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de)	1997-10-06	1999-04-08	Hoechst Marion Roussel De Gmbh	Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
AU2713799A (en)	1998-03-12	1999-09-27	Novo Nordisk A/S	Modulators of protein tyrosine phosphatases (ptpases)
KR100720844B1 (ko) *	1998-07-08	2007-05-25	사노피-아벤티스 도이칠란트 게엠베하	황 치환된 설포닐아미노카복실산 ｎ-아릴아미드, 이의 제조방법, 및 이를 함유하는 약제학적 제제
HN2000000051A (es)	1999-05-19	2001-02-02	Pfizer Prod Inc	Derivados heterociclicos utiles como agentes anticancerosos
GB0003154D0 (en) *	2000-02-12	2000-04-05	Astrazeneca Uk Ltd	Novel compounds
JP5074653B2 (ja) *	2000-03-29	2012-11-14	サイクラセルリミテッド	２−置換４−ヘテロアリール−ピリミジンおよび増殖性障害におけるその使用
US6414013B1 (en) *	2000-06-19	2002-07-02	Pharmacia & Upjohn S.P.A.	Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
JP2004523476A (ja) *	2000-10-12	2004-08-05	スミスクライン・ビーチャム・コーポレイション	ＮＦ−κＢ阻害剤
US7122544B2 (en) *	2000-12-06	2006-10-17	Signal Pharmaceuticals, Llc	Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
US20050238911A1 (en)	2001-03-16	2005-10-27	Sturley David K	Non-powered luminous panels and devices and method of manufacture
US6713638B2 (en) *	2001-05-18	2004-03-30	Joel M. Linden	2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
WO2002100851A2 (fr) *	2001-06-11	2002-12-19	Shire Biochem Inc.	Composes et procedes destines au traitement des infections par flavivirus
SE0102617D0 (sv)	2001-07-25	2001-07-25	Astrazeneca Ab	Novel compounds
SE0102616D0 (sv) *	2001-07-25	2001-07-25	Astrazeneca Ab	Novel compounds
ATE414697T1 (de) *	2001-10-04	2008-12-15	Smithkline Beecham Corp	Nf-kb-inhibitoren
WO2003028731A1 (fr)	2001-10-04	2003-04-10	Smithkline Beecham Corporation	Inhibiteurs de kinase chk1
WO2003029241A1 (fr)	2001-10-04	2003-04-10	Smithkline Beecham Corporation	Inhibiteurs de chk1 kinase
TWI281916B (en) *	2001-10-25	2007-06-01	Lilly Co Eli	Antitumor compounds and methods
US6835745B2 (en) *	2002-01-15	2004-12-28	Wyeth	Phenyl substituted thiophenes as estrogenic agents
US7196106B2 (en) *	2002-11-05	2007-03-27	Merck & Co., Inc	Cyanothiophene derivatives, compositions containing such compounds and methods of use
SE0300091D0 (sv)	2003-01-15	2003-01-15	Astrazeneca Ab	Novel compounds
SE0300092D0 (sv)	2003-01-15	2003-01-15	Astrazeneca Ab	Novel compounds

2003
- 2003-01-15 SE SE0300091A patent/SE0300091D0/xx unknown
2004
- 2004-01-13 AT AT04701632T patent/ATE374762T1/de active
- 2004-01-13 KR KR1020057013033A patent/KR20050098248A/ko not_active Ceased
- 2004-01-13 DE DE602004009283T patent/DE602004009283T2/de not_active Expired - Lifetime
- 2004-01-13 PT PT04701632T patent/PT1583756E/pt unknown
- 2004-01-13 CN CNB2004800023046A patent/CN1315820C/zh not_active Expired - Fee Related
- 2004-01-13 NZ NZ541219A patent/NZ541219A/en not_active IP Right Cessation
- 2004-01-13 WO PCT/GB2004/000106 patent/WO2004063185A1/fr not_active Ceased
- 2004-01-13 BR BR0406774-6A patent/BRPI0406774A/pt not_active IP Right Cessation
- 2004-01-13 EP EP04701632A patent/EP1583756B9/fr not_active Expired - Lifetime
- 2004-01-13 DK DK04701632T patent/DK1583756T3/da active
- 2004-01-13 CA CA002512336A patent/CA2512336A1/fr not_active Abandoned
- 2004-01-13 US US10/542,044 patent/US7553868B2/en not_active Expired - Fee Related
- 2004-01-13 MX MXPA05007340A patent/MXPA05007340A/es active IP Right Grant
- 2004-01-13 ES ES04701632T patent/ES2293206T3/es not_active Expired - Lifetime
- 2004-01-13 JP JP2006500206A patent/JP4568714B2/ja not_active Expired - Fee Related
2005
- 2005-06-27 ZA ZA200505190A patent/ZA200505190B/en unknown
- 2005-06-29 IL IL169478A patent/IL169478A/en not_active IP Right Cessation
- 2005-08-12 NO NO20053810A patent/NO20053810L/no not_active Application Discontinuation
2007
- 2007-11-29 CY CY20071101528T patent/CY1107817T1/el unknown
2009
- 2009-05-04 US US12/435,054 patent/US20090215829A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1583756B9 (fr)	2008-01-09
EP1583756A1 (fr)	2005-10-12
DE602004009283D1 (de)	2007-11-15
NZ541219A (en)	2008-03-28
IL169478A0 (en)	2009-02-11
US7553868B2 (en)	2009-06-30
KR20050098248A (ko)	2005-10-11
NO20053810D0 (no)	2005-08-12
WO2004063185A8 (fr)	2004-09-23
JP2006515355A (ja)	2006-05-25
AU2004203967A1 (en)	2004-07-29
ATE374762T1 (de)	2007-10-15
CN1315820C (zh)	2007-05-16
PT1583756E (pt)	2007-12-03
MXPA05007340A (es)	2005-09-30
ES2293206T3 (es)	2008-03-16
SE0300091D0 (sv)	2003-01-15
IL169478A (en)	2010-02-17
US20090215829A1 (en)	2009-08-27
BRPI0406774A (pt)	2005-12-27
WO2004063185A1 (fr)	2004-07-29
JP4568714B2 (ja)	2010-10-27
CN1738812A (zh)	2006-02-22
US20060111431A1 (en)	2006-05-25
CA2512336A1 (fr)	2004-07-29
CY1107817T1 (el)	2013-06-19
EP1583756B1 (fr)	2007-10-03
DK1583756T3 (da)	2007-12-17
DE602004009283T2 (de)	2008-07-10
HK1082250A1 (en)	2006-06-02
ZA200505190B (en)	2006-04-26

Publication	Publication Date	Title
CY1107817T1 (el)	2013-06-19	Καρβοξαμιδια θειοφαινιου ως αναστολεις του ενζυμου ικκ-2
BR0211473A (pt)	2004-10-26	Novos compostos
TR200401962T4 (tr)	2004-09-21	Heteroaromatik karboksamid türevleri ve bunların IKK-2 enziminin inhibitörleri olarak kullanımı
MXPA04000755A (es)	2004-04-20	Nuevos compuestos.
EA200800514A1 (ru)	2008-06-30	Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения
TW200621777A (en)	2006-07-01	New dihydropteridione derivatives, process for their manufacture and their use as medicament
SG10201809390QA (en)	2018-11-29	Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200621262A (en)	2006-07-01	New dihydropteridione derivatives, process for their manufacture and their use as medicament
NO20070339L (no)	2007-03-19	1-aza-bicyklo[3 3.1]nonaner
SE0202133D0 (sv)	2002-07-08	Novel compounds
SE0300092D0 (sv)	2003-01-15	Novel compounds
SE0401762D0 (sv)	2004-07-05	Novel compounds
ATE449069T1 (de)	2009-12-15	Aminopropanolderivate
SE0303541D0 (sv)	2003-12-22	New compounds
DK1789398T3 (da)	2011-01-24	2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
WO2006047415A3 (fr)	2006-07-06	Composes inhibiteurs du facteurs xa
CY1109371T1 (el)	2014-07-02	Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
SE0403086D0 (sv)	2004-12-17	Compounds
SE0303090D0 (sv)	2003-11-20	Novel compounds
DK1656360T3 (da)	2007-12-27	Thiazolinderivater som selektive androgenreceptor-modulatorer
YU90403A (sh)	2006-05-25	Naftotiazinski pozitivno alosterični modulatori ampa receptora (paarm)
SE0300117D0 (sv)	2003-01-17	Novel Compounds

Legal Events

Date	Code	Title	Description
2012-08-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application